Revance Net Receivables vs Total Stockholder Equity Analysis

RVNC Stock  USD 3.84  0.04  1.05%   
Revance financial indicator trend analysis is much more than just breaking down Revance prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Revance is a good investment. Please check the relationship between Revance Net Receivables and its Total Stockholder Equity accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.

Net Receivables vs Total Stockholder Equity

Net Receivables vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Revance Net Receivables account and Total Stockholder Equity. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Revance's Net Receivables and Total Stockholder Equity is -0.23. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of Revance, assuming nothing else is changed. The correlation between historical values of Revance's Net Receivables and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Revance are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Net Receivables i.e., Revance's Net Receivables and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.23
Relationship DirectionNegative 
Relationship StrengthInsignificant

Net Receivables

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from Revance's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Revance current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.At present, Revance's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Issuance Of Capital Stock is expected to grow to about 124.1 M, whereas Sales General And Administrative To Revenue is forecasted to decline to 0.16.
 2021 2022 2023 2024 (projected)
Interest Expense6.3M16.5M19.4M20.3M
Depreciation And Amortization19.9M33.7M13.7M8.0M

Revance fundamental ratios Correlations

0.60.640.330.490.740.710.590.22-0.760.750.690.880.530.50.650.920.810.740.550.770.860.540.710.94-0.34
0.60.950.6-0.350.890.930.290.88-0.930.50.080.680.950.950.930.370.880.560.980.750.820.980.930.450.01
0.640.950.67-0.290.870.940.270.82-0.920.570.120.710.910.90.910.420.890.620.940.760.830.950.940.490.04
0.330.60.67-0.350.460.490.270.6-0.520.42-0.110.480.50.480.480.10.450.350.540.450.390.630.490.180.7
0.49-0.35-0.29-0.35-0.1-0.130.48-0.70.070.290.780.19-0.35-0.37-0.220.720.050.24-0.430.10.18-0.45-0.130.64-0.46
0.740.890.870.46-0.10.910.350.7-0.930.690.240.760.820.810.960.540.910.680.890.890.890.880.910.62-0.19
0.710.930.940.49-0.130.910.390.73-0.970.650.260.70.90.910.940.530.960.630.90.850.920.91.00.61-0.17
0.590.290.270.270.480.350.390.02-0.530.610.480.330.280.30.360.660.570.550.140.510.640.170.390.69-0.12
0.220.880.820.6-0.70.70.730.02-0.710.21-0.40.440.860.850.79-0.070.620.430.90.50.520.910.730.030.21
-0.76-0.93-0.92-0.520.07-0.93-0.97-0.53-0.71-0.7-0.29-0.7-0.92-0.92-0.96-0.61-0.99-0.72-0.88-0.84-0.96-0.88-0.97-0.690.17
0.750.50.570.420.290.690.650.610.21-0.70.510.660.410.440.60.640.750.470.460.850.750.480.650.7-0.19
0.690.080.12-0.110.780.240.260.48-0.4-0.290.510.390.030.040.120.850.380.170.010.390.49-0.010.260.8-0.42
0.880.680.710.480.190.760.70.330.44-0.70.660.390.530.480.640.630.720.630.680.80.720.680.70.66-0.14
0.530.950.910.5-0.350.820.90.280.86-0.920.410.030.530.990.920.360.860.620.920.610.810.920.90.45-0.08
0.50.950.90.48-0.370.810.910.30.85-0.920.440.040.480.990.920.340.870.570.910.620.810.910.910.43-0.08
0.650.930.910.48-0.220.960.940.360.79-0.960.60.120.640.920.920.460.930.690.910.810.890.910.940.55-0.15
0.920.370.420.10.720.540.530.66-0.07-0.610.640.850.630.360.340.460.680.670.280.580.780.270.530.99-0.44
0.810.880.890.450.050.910.960.570.62-0.990.750.380.720.860.870.930.680.730.820.870.990.820.960.75-0.24
0.740.560.620.350.240.680.630.550.43-0.720.470.170.630.620.570.690.670.730.510.520.760.510.630.71-0.24
0.550.980.940.54-0.430.890.90.140.9-0.880.460.010.680.920.910.910.280.820.510.720.760.990.90.37-0.03
0.770.750.760.450.10.890.850.510.5-0.840.850.390.80.610.620.810.580.870.520.720.850.730.850.63-0.16
0.860.820.830.390.180.890.920.640.52-0.960.750.490.720.810.810.890.780.990.760.760.850.750.920.83-0.3
0.540.980.950.63-0.450.880.90.170.91-0.880.48-0.010.680.920.910.910.270.820.510.990.730.750.90.360.07
0.710.930.940.49-0.130.911.00.390.73-0.970.650.260.70.90.910.940.530.960.630.90.850.920.90.61-0.17
0.940.450.490.180.640.620.610.690.03-0.690.70.80.660.450.430.550.990.750.710.370.630.830.360.61-0.43
-0.340.010.040.7-0.46-0.19-0.17-0.120.210.17-0.19-0.42-0.14-0.08-0.08-0.15-0.44-0.24-0.24-0.03-0.16-0.30.07-0.17-0.43
Click cells to compare fundamentals

Revance Account Relationship Matchups

Revance fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets340.3M720.2M531.2M581.9M478.5M331.9M
Other Current Liab21.6M31.6M37.8M54.4M53.8M56.5M
Total Current Liabilities41.0M61.0M67.3M75.7M89.2M51.0M
Total Stockholder Equity225.5M374.3M68.5M12.6M(151.6M)(144.0M)
Other Liab47.9M77.3M75.6M80.1M92.1M96.7M
Property Plant And Equipment Net41.3M47.1M69.0M67.8M90.2M94.7M
Current Deferred Revenue7.9M7.9M9.4M6.9M10.7M7.6M
Net Debt(141.8M)(121.4M)213.9M309.5M340.6M357.6M
Retained Earnings(844.2M)(1.1B)(1.4B)(1.8B)(2.1B)(2.0B)
Accounts Payable8.0M12.7M10.6M4.5M13.8M7.0M
Cash171.2M333.6M110.6M109.0M137.9M143.2M
Non Current Assets Total43.7M270.2M285.0M207.2M139.6M90.0M
Non Currrent Assets Other1.7M4.8M13.7M35.2M32.7M34.3M
Other Assets2.4M4.8M13.7M35.2M40.5M42.6M
Cash And Short Term Investments290.1M436.5M225.1M340.7M253.9M224.4M
Common Stock Shares Outstanding43.5M58.0M67.5M72.7M84.6M88.8M
Short Term Investments119.0M102.9M114.4M231.7M116.6M81.3M
Liabilities And Stockholders Equity340.3M720.2M531.2M581.9M478.5M331.9M
Non Current Liabilities Total73.8M285.0M395.4M493.6M540.8M567.9M
Other Current Assets6.5M11.6M15.1M4.4M11.7M12.3M
Other Stockholder Equity1.1B1.5B1.5B1.8B1.9B2.0B
Total Liab114.8M345.9M462.7M569.3M630.1M661.6M
Property Plant And Equipment Gross41.3M47.1M69.0M67.8M90.2M94.7M
Total Current Assets296.6M450.0M246.1M374.7M338.9M241.9M
Accumulated Other Comprehensive Income(8K)3K(18K)(374K)14K14.7K
Short Term Debt3.5M8.9M9.5M9.8M10.9M11.8M
Property Plant Equipment14.8M17.5M69.0M67.8M77.9M81.8M
Common Stock52K69K72K82K88K83.6K
Net Tangible Assets225.5M156.0M(133.8M)(91.6M)(82.4M)(78.3M)
Retained Earnings Total Equity(684.8M)(844.2M)(1.1B)(1.4B)(1.3B)(1.2B)
Capital Surpluse830.4M1.1B1.5B1.5B1.7B1.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Revance offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Revance's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Revance Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Revance Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revance. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Revance Stock refer to our How to Trade Revance Stock guide.
You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revance. If investors know Revance will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.34)
Revenue Per Share
2.656
Quarterly Revenue Growth
0.107
Return On Assets
(0.24)
Return On Equity
(20.97)
The market value of Revance is measured differently than its book value, which is the value of Revance that is recorded on the company's balance sheet. Investors also form their own opinion of Revance's value that differs from its market value or its book value, called intrinsic value, which is Revance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revance's market value can be influenced by many factors that don't directly affect Revance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Revance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.